Business, energy, technology, markets and global industry news from Business News Today

Microsoft

PharmaDeviceNews Microsoft
Tempus AI’s PRISM2 pathology foundation model showed strong retrospective performance across cancer detection, biomarker prediction and survival analysis, strengthening interest in general-purpose artificial intelligence for digital pathology. Representative image.
Medical Devices & Diagnostics

Tempus AI trained PRISM2 on 2.3m pathology slides. Can one model detect cancer and predict what happens next?

Tempus AI’s PRISM2 foundation model matched or exceeded specialised pathology products across several retrospective cancer-detection tests while also supporting biomarker and survival predictions. The results strengthen the case for general-purpose pathology artificial intelligence, but PRISM2 is not yet an FDA-authorised diagnostic device.

Read More
A radiologist reviews AI-assisted chest CT scans as HOPPR expands developer access to medical imaging foundation models with its new chest CT narrative model. Representative image.
Medical Devices & Diagnostics

HOPPR’s chest CT model tackles radiology’s hardest AI test, but validation will decide what comes next

HOPPR adds a chest CT narrative model, widening developer access while leaving validation, regulation and workflow adoption as the key tests.

Read More